Back to results
US 10,894,804 B2Granted
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
AssigneeAtea Pharmaceuticals, Inc.
InventorsAdel Moussa, Jean-Pierre Sommadossi
Life of this patent
Estimating the term…
Abstract
A hemi-sulfate salt of the structure: to treat a host infected with hepatitis C, as well as pharmaceutical compositions and dosage forms, including solid dosage forms, thereof.
Claims37
A compound of the formula:
A compound of the formula:
A compound of the formula:
- wherein the compound is at least 90% free of the opposite phosphorus R-enantiomer.
A pharmaceutical composition comprising an effective therapeutic amount of a compound of the formula
- in a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.